Consumer goods giant Reckitt Benckiser has successfully opposed a proposed patent for a toilet bowl cleaner filed by rival S.C. Johnson, but a delegate for IP Australia has allowed the company to amend its patent application.
An Adani Group subsidiary is facing a fine of up to $2.7 million in an enforcement action by Queensland’s environment regulator over an unauthorised discharge of sediment water from its Abbot Point Coal terminal.
Plaintiffs law firm Slater & Gordon is considering a class action against gynaecologist Dr. Emil Gayed, who was found guilty of professional misconduct after patients complained of undergoing unnecessary surgery and not giving informed consent to procedures.
Biologics company Cryosite has denied claims by the ACCC that it engaged in cartel conduct by referring customers to Cell Care before their asset sale agreement was completed, saying the two were not competitors.
Concerns that the proposed acquisition of Sirtex Medical by a Chinese private equity firm would leave the company with insufficient funds to cover a settlement or judgement in a class action were eased Wednesday, after a barrister said the takeover would leave the company with just under $1 billion in assets.
The company that manufactures Botox alternatives has denied infringing on Allergan’s Botox trade mark, telling a court Wednesday its use of the word was for comparative purposes only.
Private equity firm Adcock has won almost $1 million in a judgment against the former boss of Aussie Home Loans, Stephen Porges, who was found to have misled the firm over the profitability of shares in a digital commerce startup he wanted to offload.
Facing the possibility of more class actions related its use of allegedly toxic firefighting foam at military bases throughout Australia, the Commonwealth has turned to one of the country’s largest firms for its defence in the two most recently filed cases.
Discount supermarket chain Aldi offered $150,000 to end a lawsuit brought by the maker of the popular MoroccanOil line of hair products, a court judgment revealed Tuesday.
Ophthalmic diagnostic device manufacturer ObjectiVision has made its final pitch to the Federal Court at the end of trial in a long-running intellectual property and contract dispute with the University of Sydney, saying in closing submissions that the school had run a “curious” case.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
